Claritev (NYSE:CTEV) reported first-quarter 2026 revenue and adjusted EBITDA ahead of internal expectations, while management said sales momentum and new-market expansion support its full-year outlook.President...
Q1 2026 Revenues of $244.7 million grew 5.8% compared to Q1 2025 Net Loss of $73.6...
Barchart Research What to Expect from CTEV Earnings CTEV Generated May 6, 2026 Current Price $26.47 EPS Estimate $$-3.81 Consensus Rating Moderate Buy Average Move 14.00% Can Claritev Explain Why It Keeps...
Recognition highlights Claritev’s progress embedding AI into healthcare workflows to reduce cost, improve performance, and increase transparency
Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced...
Expanding Access to Healthcare and Strengthen Community Impact
Expanding Access to Healthcare and Strengthen Community Impact
Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced...
Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, will host its...
Q4 2025 Revenues of $246.6 million, Net loss of $80.6 million, and Adjusted EBITDA of $151.3 million (Adjusted EBITDA Margin of 61.4%) Full-year...